FTSE 100 slides for fifth session as pharma shares drop
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
FTSE 100 down 0.3%, FTSE 250 down 0.2%
UK construction growth slows despite housing drive
ASOS soars as it sees core profit at top end of expectations
Pharma shares mark biggest one-day fall in near seven months
Updated at 1547 GMT
By Khushi Singh
Sept 5 (Reuters) -Britain's benchmark FTSE 100 stock index ended lower on Thursday, weighed by a decline in pharma shares, while a handful of stocks traded ex-dividend, adding to losses.
The blue-chip index .FTSE closed down 0.3%, falling for the fifth consecutive session for the first time since May.
The domestically-focused mid-cap FTSE 250 .FTMC index lost 0.2%, after touching a nearly one-month low on Wednesday.
The pharma and biotech index .FTNMX201030 was the biggest sector loser, tumbling 2.9% as drugmaker AstraZeneca AZN.L sank 3.9%.
Police in China have detained five current and former AstraZeneca employees for questioning about potential illegal activities, Bloomberg News reported, citing people familiar with the matter.
Primark owner AB Foods ABF.L was the top FTSE 100 loser, down 8.5% after the company said it expected Primark's like-for-like sales to decrease by 0.5% in second half of the year due to the unfavourable weather in Britain and Ireland.
Insurers Prudential PRU.L and Admiral ADML.L, paper and packaging firm DS Smith SMDS.L, and chemicals group Croda CRDA.L fell between 1.6% and 3.3% on trading ex-dividend.
In contrast, the homebuilders index .FTNMX402020 was the top sector performer, rising 2.6% after Vistry VTYV.L announced a share buyback worth 130 million pounds ($171 million) following a rise in half-year earnings. Vistry shares rose 8.5% to the top of FTSE 100.
Among mid-caps, Alfa Financial Software ALFAAL.L rose 10.3% rise after saying it expected full-year revenue to be 1 million pounds ahead of previous expectations.
Online retailer ASOS ASOS.L jumped 18.1% after forecasting adjusted core profit at the top end of market forecasts.
On the data front, growth in Britain's construction industry slowed in August despite the biggest pickup in homebuilding in nearly two years, adding to signs of easing inflation pressures.
British companies expect to raise selling prices by the smallest amount in nearly three years but wage growth shows no sign of cooling, another survey showed.
Reporting by Khushi Singh, Ankika Biswas in Bengaluru; Editing by Varun H K and Mark Potter
For related prices, Reuters users may click on - *
UK stock report .L
FTSE index: 0#.FTS6
techMARK 100 index: .FTT1X FTSE futures: 0#FFI:
Gilt futures: 0#FLG: Smallcap index: .FTSC
FTSE 250 index: .FTMC FTSE 350 index: .FTLC
Market digest: .AD.L Top 10 by vol: .AV.L
Top price gainers: .NG.L Top % gainers: .PG.L
Top price losers: .NL.L Top % losers: .PL.L
* For related news, click on - *
UK hot stocks: HOT and GB Wall Street: .N
Gilts report: GB/ Euro bond report GVD/EUR
Pan European stock report: .EU
Tokyo stocks: .T HK stocks: .HK
Sterling report: GBP/ Dollar report: USD/
* For company prices, click on - *
Company directory: UKEQ By sector: FTAX
* For pan-European market data, click on - *
European Equities speed guide................ EUR/EQUITY
FTSE Eurotop 300 index........................... .FTEU3
DJ STOXX index................................... .STOXX
Top 10 STOXX sectors........................ .PGL.STOXXS
Top 10 EUROSTOXX sectors................... .PGL.STOXXES
Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S
Top 25 European pct gainers.................... .PG.PEUR
Top 25 European pct losers..................... .PL.PEUR
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
